-
Likelihood of Approval and Phase Transition Success Rate Model - STX-478 in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - STX-478 in Endometrial Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. STX-478 in Endometrial Cancer Drug Details: STX-478 is under development for...
-
Likelihood of Approval and Phase Transition Success Rate Model - CR-1202 in Unspecified Gastrointestinal Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CR-1202 in Unspecified Gastrointestinal Disorders report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CR-1202 in Unspecified Gastrointestinal Disorders Drug Details: CR-1202 is under...
-
Likelihood of Approval and Phase Transition Success Rate Model - LX-2006 in Cardiomyopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LX-2006 in Cardiomyopathy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LX-2006 in Cardiomyopathy Drug Details: LX-2006 is under development for the treatment...
-
Likelihood of Approval and Phase Transition Success Rate Model - RG-6315 in Systemic Sclerosis (Scleroderma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RG-6315 in Systemic Sclerosis (Scleroderma) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RG-6315 in Systemic Sclerosis (Scleroderma) Drug Details: RG-6315 (RO-7303509) is...
-
Likelihood of Approval and Phase Transition Success Rate Model - SMART-101 in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SMART-101 in Refractory Acute Myeloid Leukemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SMART-101 in Refractory Acute Myeloid Leukemia Drug Details: SMART-101...
-
Likelihood of Approval and Phase Transition Success Rate Model - SMART-101 in Relapsed Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SMART-101 in Relapsed Acute Myeloid Leukemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SMART-101 in Relapsed Acute Myeloid Leukemia Drug Details: SMART-101...
-
Likelihood of Approval and Phase Transition Success Rate Model - AKS-452 in Coronavirus Disease 2019 (COVID-19)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AKS-452 in Coronavirus Disease 2019 (COVID-19) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AKS-452 in Coronavirus Disease 2019 (COVID-19) Drug Details: AKS-452...
-
Likelihood of Approval and Phase Transition Success Rate Model - SY-001 in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SY-001 in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SY-001 in Pancreatic Cancer Drug Details: SY-001 is under development for...
-
Likelihood of Approval and Phase Transition Success Rate Model - (Ensifentrine + Glycopyrrolate) in Chronic Obstructive Pulmonary Disease (COPD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Ensifentrine + Glycopyrrolate) in Chronic Obstructive Pulmonary Disease (COPD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Ensifentrine + Glycopyrrolate) in Chronic Obstructive...
-
Likelihood of Approval and Phase Transition Success Rate Model - LY-4052031 in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LY-4052031 in Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LY-4052031 in Ovarian Cancer Drug Details: LY-4052031 is under development for...